MedPath

Cerevance Alpha, Inc.

Ownership
Private
Employees
-
Market Cap
-
Website

CVN058 Effect on Mismatch Negativity in Schizophrenics

Phase 1
Completed
Conditions
Schizophrenia
Interventions
Other: Placebo comparator
First Posted Date
2018-09-13
Last Posted Date
2024-10-04
Lead Sponsor
Cerevance Alpha, Inc.
Target Recruit Count
22
Registration Number
NCT03669250
Locations
🇺🇸

New York State Psychiatric Institute, New York, New York, United States

🇺🇸

Icahn School of Medicine at Mount Sinai, New York, New York, United States

🇺🇸

Nathan Kline Institute, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath